Selvan Ravindran

576 total citations
40 papers, 381 citations indexed

About

Selvan Ravindran is a scholar working on Molecular Biology, Materials Chemistry and Biomaterials. According to data from OpenAlex, Selvan Ravindran has authored 40 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Materials Chemistry and 5 papers in Biomaterials. Recurrent topics in Selvan Ravindran's work include Nanoparticles: synthesis and applications (6 papers), Nanoparticle-Based Drug Delivery (4 papers) and Gestational Diabetes Research and Management (4 papers). Selvan Ravindran is often cited by papers focused on Nanoparticles: synthesis and applications (6 papers), Nanoparticle-Based Drug Delivery (4 papers) and Gestational Diabetes Research and Management (4 papers). Selvan Ravindran collaborates with scholars based in India, United States and Greece. Selvan Ravindran's co-authors include Anuradha Vaidya, Olga L. Zharikova, Mahmoud Ahmed, Tatiana Nanovskaya, Ronald A. Hill, Gary D.V. Hankins, Pooja Singh, Sambhaji S. Pisal, Sudipta Basu and Mandar M. Shirolkar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and American Journal of Obstetrics and Gynecology.

In The Last Decade

Selvan Ravindran

36 papers receiving 368 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Selvan Ravindran India 10 104 75 65 59 38 40 381
Eric A. Tanifum United States 14 154 1.5× 95 1.3× 73 1.1× 55 0.9× 14 0.4× 27 485
Aliyah Almomen Saudi Arabia 14 132 1.3× 51 0.7× 51 0.8× 93 1.6× 9 0.2× 46 549
Osama M. Al‐Amer Saudi Arabia 13 95 0.9× 90 1.2× 51 0.8× 30 0.5× 18 0.5× 45 525
Dongmei Yan China 14 169 1.6× 54 0.7× 109 1.7× 42 0.7× 11 0.3× 60 575
I. Muchá Poland 11 55 0.5× 94 1.3× 32 0.5× 18 0.3× 30 0.8× 60 458
Mohammad Mohammadi Iran 10 113 1.1× 59 0.8× 47 0.7× 19 0.3× 12 0.3× 30 395
Hazem Ali United States 10 109 1.0× 50 0.7× 28 0.4× 76 1.3× 24 0.6× 10 465
Archana S. Patil India 13 45 0.4× 50 0.7× 37 0.6× 51 0.9× 13 0.3× 65 398
Na Zhao China 11 110 1.1× 64 0.9× 27 0.4× 30 0.5× 47 1.2× 32 519

Countries citing papers authored by Selvan Ravindran

Since Specialization
Citations

This map shows the geographic impact of Selvan Ravindran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Selvan Ravindran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Selvan Ravindran more than expected).

Fields of papers citing papers by Selvan Ravindran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Selvan Ravindran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Selvan Ravindran. The network helps show where Selvan Ravindran may publish in the future.

Co-authorship network of co-authors of Selvan Ravindran

This figure shows the co-authorship network connecting the top 25 collaborators of Selvan Ravindran. A scholar is included among the top collaborators of Selvan Ravindran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Selvan Ravindran. Selvan Ravindran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vaidya, Anuradha, et al.. (2025). Polymeric nanoparticles-based targeted delivery of drugs and bioactive compounds for arthritis management. Future Science OA. 11(1). 2467591–2467591. 9 indexed citations
2.
Vaidya, Anuradha, et al.. (2025). Impact of particle size and surface modifications on the neurotoxic potential of copper oxide nanoparticles. Scientific Reports. 15(1). 44532–44532.
3.
4.
Ravindran, Selvan, et al.. (2024). Selective Identification of Ferric Ionsin Ecological and Biological SamplesUsing Rhodamine Chemosensors. Polish Journal of Environmental Studies. 3 indexed citations
5.
Ravindran, Selvan, et al.. (2024). Platelet-rich plasma treatment for knee osteoarthritis: A systematic investigation. Multidisciplinary Reviews. 6. 2023ss015–2023ss015. 1 indexed citations
6.
Ravindran, Selvan, et al.. (2024). <i>Beta vulgaris</i> L. Extract Mediated BiogenicSynthesis of Magnesium Oxide Nanostructuresand their Enhanced Antibacterial, Antioxidant,and Cytocompatibility Activities. Polish Journal of Environmental Studies. 33(4). 4551–4559. 1 indexed citations
7.
Vaidya, Anuradha, et al.. (2024). Therapeutic potential of antibody-drug conjugates possessing bifunctional anti-inflammatory action in the pathogenesis of rheumatoid arthritis. Arthritis Research & Therapy. 26(1). 216–216. 3 indexed citations
8.
Ravindran, Selvan, et al.. (2024). Nano-radiopharmaceuticals as therapeutic agents. Frontiers in Medicine. 11. 1355058–1355058. 8 indexed citations
9.
10.
Ravindran, Selvan, et al.. (2023). Antiviral and ROS scavenging potential of Carica papaya Linn and Psidium guajava leaves extract against HIV-1 infection. BMC Complementary Medicine and Therapies. 23(1). 82–82. 17 indexed citations
11.
Vaidya, Anuradha, et al.. (2022). Toxic implications of silver nanoparticles on the central nervous system: A systematic literature review. Journal of Applied Toxicology. 43(1). 4–21. 41 indexed citations
12.
Ravindran, Selvan, et al.. (2022). Protective effects of recombinant human golimumab and pentoxifylline in nephrotoxicity induced by cisplatin. Journal of Biochemical and Molecular Toxicology. 36(4). e22990–e22990. 4 indexed citations
13.
Ravindran, Selvan, et al.. (2021). Amelioration of Cisplatin-induced Renal Inflammation by Recombinant Human Golimumab in Mice. Current Pharmaceutical Biotechnology. 23(7). 970–977. 3 indexed citations
14.
Ravindran, Selvan, et al.. (2021). Rhodamine B and Rhodamine 6G Based Sensingof Copper Ions in Environmental and BiologicalSamples: Recent Progress. Polish Journal of Environmental Studies. 30(4). 3445–3455. 12 indexed citations
15.
Ravindran, Selvan, et al.. (2019). Nanomedicine: Bioavailability, Biotransformation and Biokinetics. Current Drug Metabolism. 20(7). 542–555. 20 indexed citations
16.
Ravindran, Selvan, et al.. (2019). Monoclonal antibody purification and its progression to commercial scale. Biologicals. 63. 1–13. 26 indexed citations
17.
Ravindran, Selvan, et al.. (2014). Metabolite Characterization of Anti-cancer Agent Gefitinib in Human Hepatocytes. Drug Metabolism Letters. 7(2). 126–136. 7 indexed citations
18.
Jain, Sangeeta, Olga L. Zharikova, Selvan Ravindran, et al.. (2008). Glyburide Metabolism by Placentas of Healthy and Gestational Diabetics. American Journal of Perinatology. 25(3). 169–174. 7 indexed citations
19.
Zharikova, Olga L., Selvan Ravindran, Tatiana Nanovskaya, et al.. (2007). Kinetics of glyburide metabolism by hepatic and placental microsomes of human and baboon. Biochemical Pharmacology. 73(12). 2012–2019. 26 indexed citations
20.
Ravindran, Selvan, Olga L. Zharikova, Ronald A. Hill, et al.. (2006). Identification of glyburide metabolites formed by hepatic and placental microsomes of humans and baboons. Biochemical Pharmacology. 72(12). 1730–1737. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric A. Tanifum Breakdown of academic impact, for papers by Aliyah Almomen Breakdown of academic impact, for papers by Osama M. Al‐Amer Breakdown of academic impact, for papers by Dongmei Yan Breakdown of academic impact, for papers by I. Muchá Breakdown of academic impact, for papers by Mohammad Mohammadi Breakdown of academic impact, for papers by Hazem Ali Breakdown of academic impact, for papers by Archana S. Patil Breakdown of academic impact, for papers by Na Zhao
Rankless by CCL
2026